tisotumab vedotin

FDA Drug Profile — TIVDAK

Drug Details

Generic Name
tisotumab vedotin
Brand Names
TIVDAK
Application Number
BLA761208
Sponsor
Bamboo US Bidco LCC
NDC Codes
3
Dosage Forms
INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
TISOTUMAB VEDOTIN

Indications and Usage

1 INDICATIONS AND USAGE TIVDAK ® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. TIVDAK is a tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. ( 1 )